Article
Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery…
Mediators of Inflammation · 2016 · Fangchen Gong, author Jin Wu, author Ping Zhou, author Mengyao Zhang, author Jingning Liu, author Ying Liu, author Xiang Lu, author Zhengxia Liu, author Chiara De Luca, Academic Editor
Key facts
| Title | Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease |
|---|---|
| First author | Fangchen Gong, author Jin Wu, author Ping Zhou, author Mengyao Zhang, author Jingning Liu, author Ying Liu, author Xiang Lu, author Zhengxia Liu, author Chiara De Luca, Academic Editor |
| Journal | Mediators of Inflammation |
| Published | Apr 13, 2016 |
| DOI | 10.1155/2016/8254797 |
| Devices mentioned | K073506, K083846, K121399, K133302, K140377 |
| Product codes mentioned | NSU, NUA, PCH |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1